Matching slides 58,039
Current window 33,691-33,720
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all

Slide function

33,691-33,720 of 58,039

filter-aware
15
The table provides a comprehensive view of the company's lending activities, categorized by segment and product type.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Evidence1 hit
17
The slide uses a pie chart to show portfolio composition and a line chart to show historical performance metrics.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Evidence1 hit
18
Includes disclaimer regarding forward-looking modeling and regulatory purpose of data.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Evidence1 hit
19
Includes three combo charts (bar/line) and a summary list of key credit metrics.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Evidence1 hit
20
Includes a footnote regarding CECL transition and preliminary reporting status.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Evidence1 hit
22
Standard financial disclosure slide for non-GAAP metrics.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
23
The table shows the impact of excluding tax services on NCO ratios.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
24
The slide provides a transparent breakdown of GAAP to non-GAAP adjustments for efficiency metrics.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
25
The chart uses NAICS industry classifications. The bottom section provides a granular breakdown of product types for Manufacturing, Transportation & Warehousing, and Utilities.Pathward Financial | Results Presentation Deck | 25 slides · Pathward Financial
Conference presentation Investor relations Beat · Appendix1 hit
15
The slide uses a funnel-style comparison for attrition rates, followed by two bar charts for cost and time.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
30
The diagram uses a hub-and-spoke style visualization where 'Breast Cancer' is the central node connected to a subset of genes, while others are peripheral.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
31
The diagram uses a chord-like visualization to map gene associations to a central Breast Cancer node.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
33
The diagram uses a circular layout with nodes on the perimeter and connecting arcs representing relationships. Labels include gene names (e.g., KRAS, NRAS, BRAF) and drug names (e.g., AZD4547, ENCORAFENIB).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
58
The slide uses a 'problem-solution' structure, contrasting the high unmet need in cancer patients (left) with the efficacy of the REC-0648918 compound in mouse models (right).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
63
The slide highlights a specific subset of data (Compound 2A/2B) where phenomics shows a dramatic improvement, suggesting a redirection of chemistry efforts.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
64
The slide contrasts standard dose-response curves (univariate) with a phenotypic similarity matrix (heatmap) to highlight the value of phenomics in drug discovery.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
70
The slide uses two line charts to demonstrate efficacy. The top banner indicates the context is HR-proficient ovarian cancer PDX.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
77
The heatmap displays gene expression or similarity data across different concentrations of EW-719.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
78
The pyramid represents the 'Recursion Data Universe' (>21 PB).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
92
Slide 92 of a presentation deck.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
94
The table compares Placebo against 50mg, 200mg, 400mg, and 800mg doses across various safety metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
101
The slide uses a split-screen layout to compare two different preclinical efficacy studies.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
110
The slide uses two distinct chart types (bar chart with error bars and dot plot with mean/SEM bars) to demonstrate efficacy across two metrics.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
116
The slide uses a heatmap to demonstrate biological similarity between drug dosage effects and specific gene regulation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
117
The slide compares efficacy in mutant vs wildtype models using bar charts for tumor growth inhibition and Kaplan-Meier curves for progression-free survival.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
03
Includes non-GAAP financial measure disclosures.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · Attention1 hit
04
The slide uses a stacked bar chart for total deposits and a horizontal bar chart for growth composition by segment.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations 1 hit
05
Includes footnotes regarding composition exclusions and CRE-Other definition.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations 1 hit
06
The Q4 2022 column is highlighted with a box.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations 1 hit
07
Includes a dual-axis chart and a table of quarterly changes.Signature Bank | Results Presentation Deck | 30 slides · Signature Bank
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit